Endosomal/Vacuolar pathway
REACTOME PATHWAYThe Endosomal/Vacuolar pathway pathway (Reactome ID: R-HSA-1236977) involves 3 genes and is affected by 37 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.
Genes in this Pathway
Compounds Affecting Endosomal/Vacuolar pathway
| # | Compound | Targets Hit | Studies |
|---|---|---|---|
| 1 | Camptothecin | — | 300 |
| 2 | Ouabain | — | 300 |
| 3 | withaferin | — | 300 |
| 4 | celastrol | — | 300 |
| 5 | Disulfiram | — | 297 |
| 6 | Idarubicin | — | 299 |
| 7 | Azacitidine | — | 298 |
| 8 | Azacitidine | — | 300 |
| 9 | Bortezomib | — | 300 |
| 10 | Calcimycin | — | 216 |
| 11 | Crizotinib | — | 298 |
| 12 | cycloheximide | — | 300 |
| 13 | Dactinomycin | — | 297 |
| 14 | Daunorubicin | — | 298 |
| 15 | Emetine | — | 298 |
| 16 | Epirubicin | — | 300 |
| 17 | Homoharringtonine Semisynthetic derivative of harringtonine that acts as | — | 300 |
| 18 | 3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one [Supplementary Concept] | — | 1 |
| 19 | kenpaullone | — | 8 |
| 20 | Proscillaridin | — | 219 |
| 21 | trichostatic acid [Supplementary Concept] related to trichostatin | — | 300 |
| 22 | Tripterygium | — | 300 |
| 23 | cbd | — | 298 |
| 24 | Genistein | — | 300 |
| 25 | Sertraline | — | 1,000 |
| 26 | cannabidiol | — | 296 |
| 27 | Deslanoside Deacetyllanatoside C. | — | 89 |
| 28 | Digitoxin | — | 300 |
| 29 | Digoxin | — | 299 |
| 30 | Feprazone | — | 63 |
| 31 | Leflunomide | — | 297 |
| 32 | Nitrendipine | — | 299 |
| 33 | Phenylbutazone | — | 300 |
| 34 | triolimus [Supplementary Concept] | — | 33 |
| 35 | Thapsigargin | — | 300 |
| 36 | Astemizole Antihistamine drug now withdrawn from | — | 280 |
| 37 | Triamcinolone | — | 300 |
About the Endosomal/Vacuolar pathway Pathway
The Endosomal/Vacuolar pathway pathway is catalogued in Reactome (ID: R-HSA-1236977) and involves 3 genes. In the BiohacksAI corpus, 37 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include CTSL, HLA-A, HLA-B.